AKTX
Akari Therapeutics PLC
NASDAQ: AKTX · HEALTHCARE · BIOTECHNOLOGY
$5.35
+2.10% today
Updated 2026-04-30
Market cap
$6.00M
P/E ratio
0.00
P/S ratio
478,368.50x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$3 – $59
Volume
0.3M
Akari Therapeutics PLC (AKTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-366000.00 | $-1.01M | $-2.13M | $-5.45M | $-9.46M | $-4.97M | $-24.62M | $-31.60M | $-22.54M | $-12.92M | $-16.95M | $-18.85M | $-21.50M | $-16.43M | $-12.55M | $-10.57M |
| Capital expenditures | $0.00 | $0.00 | $4000.00 | $0.00 | $57000.00 | $10560.00 | $54750.00 | $36885.00 | $36885.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $140000.00 | $514000.00 | $94000.00 | $468000.00 | $1.79M | $3.93M | $2.73M | $1.65M | $1.05M | $325523.00 | $314650.00 | $735000.00 | $1.15M | $2.25M | $2.89M |
| Free cash flow | $-366000.00 | $-1.01M | $-2.14M | $-5.45M | $-9.52M | $-4.98M | $-24.68M | $-31.64M | $-22.57M | $-12.92M | $-16.95M | $-18.85M | $-21.50M | $-16.43M | $-12.55M | $-10.57M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |